A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
作者信息
Popat Uday R, Andersson Borje S, Bassett Roland, Kawedia Jitesh, Valdez Ben C, Alousi Amin M, Al-Atrash Gheath, Bashir Qaiser, Hosing Chitra M, Im Jin S, Kebriaei Partow, Marin David, Nieto Yago, Oran Betul, Olson Amanda, Qazilbash Muzaffar H, Srour Samer A, Shpall Elizabeth J, Champlin Richard E, Mehta Rohtesh S
机构信息
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
出版信息
Haematologica. 2022 Oct 1;107(10):2496-2500. doi: 10.3324/haematol.2022.280778.
Abstract
摘要
Zotero 插件